About API Pharma

Founded as a social business by Joseph Trentin and based in Alexandria, Virginia, API Pharma (API) is an industry leader in designing and distributing rapid tests for a range of viruses and diseases, including rotovirus, influenza, hepatitis, herpes, HIV, and others.

API’s rapid COVID-19 test is nearly as simple as a home pregnancy test, requiring only a few drops of blood from a finger stick and a drop of reagent. Results are available in under 20 minutes and are simple to interpret: one line means negative, two lines means positive. The test has 97% sensitivity and 97% specificity, and API’s long experience with rapid tests makes it a reliable provider. API currently has approval to provide test kits to medical facilities in the U.S. and expects to have FDA approval for home use soon. The test is already in use in Europe.